24: Proffered Paper: JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: A rationale for co-targeting these pathways in metastatic breast cancer

Autor:	T. Radimerski, I. Klebba, M. Bentires-Alj, A. Britschgi, U. Mueller, R. Andraos, H. Brinkhaus, V. Romanet, M. Murakami
Rok vydání:	2014
Předmět:	Cancer Research biology business.industry Pharmacology medicine.disease Metastatic breast cancer Blockade Oncology Cancer research medicine biology.protein business PI3K/AKT/mTOR pathway STAT5
Zdroj:	European Journal of Cancer. 50:S7
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(14)50024-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::60f213d31579ffcd4277f3216535f9fc https://doi.org/10.1016/s0959-8049(14)50024-x Zobrazit plný text záznamu Full Text from ScienceDirect